| Literature DB >> 30050386 |
Luca Prosperini1, Letizia Castelli2.
Abstract
Multiple sclerosis (MS) is a disease that heavily affects postural control, predisposing patients to accidental falls and fall-related injuries, with a relevant burden on their families, health care systems and themselves. Clinical scales aimed to assess balance are easy to administer in daily clinical setting, but suffer from several limitations including their variable execution, subjective judgment in the scoring system, poor performance in identifying patients at higher risk of falls, and statistical concerns mainly related to distribution of their scores. Today we are able to objectively and reliably assess postural control not only with laboratory-grade standard force platform, but also with low-cost systems based on commercial devices that provide acceptable comparability to gold-standard equipment. The sensitivity of measurements derived from force platforms is such that we can detect balance abnormalities even in minimally impaired patients and predict the risk of future accidental falls accurately. By manipulating sensory inputs (dynamic posturography) or by adding a concurrent cognitive task (dual-task paradigm) to the standard postural assessment, we can unmask postural control deficit even in patients at first demyelinating event or in those with a radiologic isolated syndrome. Studies on neuroanatomical correlates support the multifactorial etiology of postural control deficit in MS, with the association with balance impairment being correlated with cerebellum, spinal cord, and highly ordered processing network according to different studies. Postural control deficit can be managed by means of rehabilitation, which is the most important way to improve balance in patients with MS, but there are also suggestions of a beneficial effect of some pharmacologic interventions. On the other hand, it would be useful to pay attention to some drugs that are currently used to manage other symptoms in daily clinical setting because they can further impair postural controls of patients with MS.Entities:
Keywords: accidental falls; balance; cognitive-motor interference; force platform; multiple sclerosis; postural control
Year: 2018 PMID: 30050386 PMCID: PMC6053902 DOI: 10.2147/DNND.S135755
Source DB: PubMed Journal: Degener Neurol Neuromuscul Dis ISSN: 1179-9900
Figure 1Schematic of postural control and its alterations in MS.
Abbreviation: MS, multiple sclerosis.
Figure 2Consequences of postural control deficit in multiple sclerosis.
Case–control studies exploring the incidence of fall-related fractures and injuries in patients with multiple sclerosis
| Study | Average age (years) | Cases | Controls | Outcome | Risk |
|---|---|---|---|---|---|
| Bazelier et al | 44.8 | 5,565 | 33,360 | Any fracture | 1.2 |
| Hip fractures | 2.8 | ||||
| Osteoporotic fractures | 1.4 | ||||
| Cameron et al | 60.3 | 721 | 194,696 | Injurious falls | 1.9 |
| Bazelier et al | 43.6 | 2,415 | 12,641 | Any fracture | 0.8 |
| Fall-related fractures | 2.1 | ||||
| Bazelier et al | 36.9 | 2,963 | 15,436 | Any fracture | 1.0 |
| Femur/hip fractures | 1.9 | ||||
| Ramagopalan et al | ~50 | 87,873 | 7,820,697 | Any fracture | 1.9 |
| Femoral fractures | 2.8 | ||||
| Bhattacharya et al | ~65 | 2,631 | 1,063,773 | Hip fractures | 2.2 |
Notes:
Values >1 indicate increased risk in patients with multiple sclerosis.
Clinical scales currently used to assess postural control and balance in multiple sclerosis
| Instrument | Brief description | Time of administration | Overall score | Direction |
|---|---|---|---|---|
| Activities-Specific Balance Confidence | 16-item self-administered questionnaire | 15 minutes | 0–100 | ↓ |
| Balance Evaluation System Test | 36-item physician-rated scale | 30 minutes | 0–108 | ↓ |
| Berg Balance Scale | 14-item physician-rated scale | 15 minutes | 0–56 | ↓ |
| Dizziness Handicap Inventory | Multidimensional 25-item self-administered questionnaire | 15 minutes | 0–100 | ↑ |
| Dynamic Gait Index | 8-item physician-rated scale | 10 minutes | 0–24 | ↓ |
| Falls Efficacy Scale International | 16-item self-reported questionnaire | 10 minutes | 0–100 | ↑ |
| Four-Square Step Test | Stop-watch measurement | ≤3 minutes | N/A | ↑ |
| Mini-BES Test | 14-item physician-rated scale | 10–15 minutes | 0–28 | ↓ |
| Timed Up-and-Go Test | Stop-watch measurement | ≤3 minutes | N/A | ↑ |
| Tinetti Performance-Oriented Mobility Assessment | 16-item physician-rated scale | 10–15 minutes | 0–48 | ↓ |
Note: Worse postural control indicated by lower (↓) or higher (↑) scores.
Abbreviation: N/A, not applicable.
Figure 3Statokinesigrams collected by one healthy volunteer, one patient who did not report any fall and one patient who reported three accidental falls within the last 3 months.
Abbreviation: MS, multiple sclerosis.
Figure 4Patterns of cognitive-postural interference based on the reciprocal DTC of balance and cognition.
Note: The asterisk indicates no interference.
Abbreviation: DTC, dual-task cost.
List of medications potentially affecting postural control in multiple sclerosis
| Deteriorating postural control | Improving postural control |
|---|---|
| Centrally acting muscle relaxants | Prolonged-release fampridine |
| Selective serotonin reuptake inhibitor | Riluzole |
| Serotonin-norepinephrine reuptake inhibitor | Dopamine agonists |
| Genitourinary compounds | |
| Cannabis | |
| Sexual hormones |